Wednesday, October 4, 2023
HomeVenture Capital

Venture Capital

Venture Capital

Mogrify Extends Series A Financing to $46 Million USD

Life Sciences Times - 0
Venture Capital

Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D

Life Sciences Times - 0
Venture Capital

Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development

Life Sciences Times - 0
Venture Capital

Ligand Acquires Assets of Novan, Inc. for $12.2 Million

Life Sciences Times - 0
Venture Capital

Novel Biotechnology Inc. Secures $2.5 Million in Seed Round Funding

Life Sciences Times - 0
Venture Capital

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Life Sciences Times - 0
Venture Capital

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

Life Sciences Times - 0
Venture Capital

SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines

Life Sciences Times - 0
Venture Capital

Virtual Incision Extends Series C Round with Additional $30M Funding

Life Sciences Times - 0
Venture Capital

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

Life Sciences Times - 0
Venture Capital

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

Life Sciences Times - 0
Venture Capital

ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension to Support Advancement of Lead Program into Clinical Development for Autoimmune Disease

Life Sciences Times - 0
123...74Page 1 of 74

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv